Table 1 Clinical profile of the 10 patients with LG-EESS
Parameter | Number | Percent (%) |
|---|---|---|
Age at diagnosis (median, range), year | 44.5 | 33–66 |
Initial clinical presentation | ||
Vaginal bleeding | 2 | 20 |
Abd distention | 3 | 30 |
Abd pain | 2 | 20 |
Pruritus vulvae | 1 | 10 |
Dysmenorrhea | 1 | 10 |
None | 1 | 10 |
History of gynecologic surgery | ||
TAH for leiomyoma | 4 | 40% |
CA125 (median, range), U/ml | 49.5 | 15.4–168.0 |
Site of tumor | ||
Vaginal wall | 2 | 20 |
Sigmoid | 3 | 30 |
Right ovary | 3 | 30 |
Vulva | 1 | 10 |
Pelvis | 1 | 10 |
Initial surgery | ||
Optimal tumor resection (R0 resection) | 5 | 50% |
LND | 4 | 40 |
Stage | ||
I | 0 | 0 |
II | 2 | 20 |
III | 5 | 50 |
IIII | 3 | 30 |
Adjuvant treatment | ||
QT | 2 | 20 |
HT | 3 | 30 |
QT+RT | 2 | 20 |
QT+HT | 3 | 30 |
Follow up (median, range), month | 94 | 27–228 |
Relapse | 3 | 30 |
Current status | ||
AWD | 3 | 30 |
NED | 7 | 70 |